Loading…
Grace Analytical Lab Inc received an FDA Warning Letter on November 19, 2019 regarding drug products, though the specific violations cannot be detailed as the subject line and full letter text are not available. Based on the limited metadata provided, this appears to be a drug manufacturing or testing facility that failed to meet FDA regulatory requirements, but the exact nature of the compliance issues cannot be determined without access to the complete correspondence. To understand the specific violations and required corrective actions, the full Warning Letter text would need to be reviewed.